[
    [
        {
            "time": "2021-08-26",
            "original_text": "泰格医药：扣非持续亮眼 新签订单大幅增长 主业加速恢复",
            "features": {
                "keywords": [
                    "泰格医药",
                    "新签订单",
                    "大幅增长",
                    "主业恢复"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "泰格医药：扣非持续亮眼 新签订单大幅增长 主业加速恢复",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-08-26",
            "original_text": "泰格医药2021年中报点评：21H1国际业务占比持续提升 在手订单金额增长超出预期",
            "features": {
                "keywords": [
                    "泰格医药",
                    "中报",
                    "国际业务",
                    "订单增长"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "泰格医药2021年中报点评：21H1国际业务占比持续提升 在手订单金额增长超出预期",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-08-26",
            "original_text": "订单量增长25%！中期营收超预期，“投资+CRO”双轮驱动下，泰格医药“项庄舞剑意在沛公”",
            "features": {
                "keywords": [
                    "订单量增长",
                    "营收超预期",
                    "投资+CRO",
                    "泰格医药"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "订单量增长25%！中期营收超预期，“投资+CRO”双轮驱动下，泰格医药“项庄舞剑意在沛公”",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-08-26",
            "original_text": "泰格医药2021年上半年营收20.56亿元 同比增长41.62%",
            "features": {
                "keywords": [
                    "泰格医药",
                    "营收增长",
                    "上半年"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "泰格医药2021年上半年营收20.56亿元 同比增长41.62%",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-08-26",
            "original_text": "跌出价值！千亿白马频现回购，强护盘模式开启",
            "features": {
                "keywords": [
                    "跌出价值",
                    "回购",
                    "护盘"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "跌出价值！千亿白马频现回购，强护盘模式开启",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-08-26",
            "original_text": "泰格医药亮业绩 股价跌4.8% 上半年ROE毛利率均降 盈利能力下降",
            "features": {
                "keywords": [
                    "泰格医药",
                    "股价下跌",
                    "盈利能力下降"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "泰格医药亮业绩 股价跌4.8% 上半年ROE毛利率均降 盈利能力下降",
                "Correlation": 10,
                "Sentiment": 4,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-08-26",
            "original_text": "【异动股】泰格医药(03347.HK)跌3.08%",
            "features": {
                "keywords": [
                    "异动股",
                    "泰格医药",
                    "股价下跌"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "【异动股】泰格医药(03347.HK)跌3.08%",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 6,
                "Impact": 6,
                "Duration": 4,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-08-26",
            "original_text": "【AH互动】泰格医药(03347)中期纯利同比增25.65% H股涨3.8%",
            "features": {
                "keywords": [
                    "AH互动",
                    "泰格医药",
                    "中期纯利增长",
                    "H股上涨"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【AH互动】泰格医药(03347)中期纯利同比增25.65% H股涨3.8%",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-08-26",
            "original_text": "港股异动︱泰格医药(03347)涨超6% 中期归母净利同比增长25.65%至12.55亿元",
            "features": {
                "keywords": [
                    "港股异动",
                    "泰格医药",
                    "归母净利增长"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "港股异动︱泰格医药(03347)涨超6% 中期归母净利同比增长25.65%至12.55亿元",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-08-26",
            "original_text": "港股异动 | 泰格医药(3347.HK)涨5.68% 上半年净利升25.65%至12.55亿元",
            "features": {
                "keywords": [
                    "港股异动",
                    "泰格医药",
                    "净利上升"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "港股异动 | 泰格医药(3347.HK)涨5.68% 上半年净利升25.65%至12.55亿元",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]